AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 18.92 |
Market Cap | 332.04M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 0.86 |
PE Ratio (ttm) | 26.06 |
Forward PE | n/a |
Analyst | Hold |
Ask | 25.2 |
Volume | 51,801 |
Avg. Volume (20D) | 87,227 |
Open | 22.18 |
Previous Close | 22.17 |
Day's Range | 22.16 - 22.60 |
52-Week Range | 9.93 - 28.61 |
Beta | undefined |
About LWAY
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and...
Analyst Forecast
According to 5 analyst ratings, the average rating for LWAY stock is "Hold." The 12-month stock price forecast is $19.5, which is a decrease of -12.99% from the latest price.
Next Earnings Release
Analysts project revenue of $47.50M, reflecting a 12.85% YoY growth and earnings per share of 0.18, making a -30.77% decrease YoY.
1 month ago · seekingalpha.com
Lifeway Foods: Still 'In Play' Despite Two Rebuffed Takeover OffersLifeway Foods has rejected not one, but two takeover offers from Danone, but the kefir and fermented probiotic food products company remains "in play." The latest in an ongoing saga amongst the compan...